Amgen data breach patient health info
Analysis based on 6 articles · First reported Jul 31, 2026 · Last updated Aug 02, 2026
The breach may raise concerns about data security and regulatory compliance, potentially pressuring Amgen's stock in the short term. However, the lack of operational impact and the company's swift response may mitigate long-term financial damage.
Amgen disclosed a cybersecurity breach on July 31, 2026, in which hackers stole company data and patient health information from cloud storage systems operated by third-party providers. The company determined the incident was material on July 29, based on the number of affected files and potential sensitivity of the data. Amgen activated its cybersecurity response plan, implemented containment measures, and engaged independent forensic experts. It is assessing the extent of access to patient data, confidential business information, intellectual property, and R&D. No impact on products, manufacturing, financial reporting, or patient needs has been found so far. The breach adds to a wave of cyberattacks in the healthcare sector, with Abbott Laboratories, Clover Health, Stryker, Medtronic, Novo Nordisk, and KC Pharmaceuticals also recently affected. Amgen is also facing separate regulatory scrutiny over its rare-disease drug Tavneos.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard